Folic acid-modified bovine serum albumin targeted delivery of curcumin induces ferroptosis and apoptosis in glioma cells
Year: 2026
Type: article
Abstract: Purpose This study aims to construct a folate-modified bovine serum albumin (BSA) nanocarrier for targeted curcumin(Cur) delivery to glioma cells and evaluate its anti-glioma efficacy via ferroptosis and apoptosis pathways. Methods Folate-BSA-curcumin nanoparticles (Cur@BSA-FA) were prepared by the desolvation method. Physicochemical characterization included particle size, Zeta potential, Fourier-transform infrared spectroscopy, transmission electron microscopy, drug loading, and in vitro release. Anti-glioma activity was assessed in C6 glioma cells using the cell counting kit-8, wound healing, colony formation, reactive oxygen species (ROS), malondialdehyde (MDA), lipid hydroperoxide (LPO), iron levels, apoptosis, glutathione peroxidase 4 (GPX4), and Bcl-2 protein expression. In vivo efficacy was evaluated in subcutaneous xenograft models. Results Cur@BSA-FA exhibited a favorable particle size (122.4 nm), negative Zeta potential, sustained release profile, and high drug loading. The nanoparticles significantly inhibited cell proliferation, wound closure, and colony formation in a dose-dependent manner. Mechanistically, Cur@BSA-FA elevated ROS, MDA, LPO, and iron levels while downregulating GPX4 and Bcl-2, indicating synergistic ferroptosis and apoptosis. In vivo , the nanosystem significantly suppressed tumor growth with good biosafety. Conclusions Cur@BSA-FA mediates targeted delivery at least partially via folate receptor-mediated endocytosis and induces both ferroptosis and apoptosis in C6 glioma cells, suggesting a potential nanotherapeutic strategy that warrants further evaluation in orthotopic glioma models.
Source: Frontiers in Oncology
Authors: Yufeng Qian, Wei Peng, Yadi Mao, Chao Huang, Lixia Yang
Institutions: Shaoxing University, Shaoxing People's Hospital
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236179978
